On behalf of the Indiana Health Industry Forum (IHIF), please join us for a special briefing to discuss the critical importance of SBIR/STTR programs as economic drivers that support American innovation and small businesses.
On September 13, AdvaMed, BIO, and the Council of State Bioscience Associations (CSBA) will host a special briefing to discuss the success of SBIR/STTR programs, their economic impact, and the important next steps to Federal reauthorization.
What: SBIR/STTR Reauthorization Webinar
Where: Zoom Webinar
When: Tuesday, September 13, 2022, 1:00PM – 2:00PM ET
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are highly competitive award-based programs that encourage domestic small businesses to engage in Federal Research/Research and Development with the potential for commercialization.
Federal funding for the SBIR/STTR Program will expire on September 30, 2022, and we need your support to ensure timely reauthorization!
Hear from successful SBIR/STTR grantees, program officers, and technical experts on these vital programs. After this webinar, you will be able to effectively advocate for Federal SBIR/STTR program reauthorization.
– John Conrad, President & CEO of iBio (Illinois)
– Matt McMahon, Director, NIH SEED Office
– Maureen Mulvihill, CEO, Actuated Medical
– Erika Smith, CEO, ReNetX Bio
– Michael P. Wallner, MBA, MPA, PhD, Department Head, Economic Impacts, TechLink-A
The Indiana Health Industry Forum provides guidance and leadership on public policy issues that contribute to innovation in the health science sector, deliver therapies to patients in need, and further the development and growth of our member companies. IHIF works at the federal and state level and partners with several other organizations and groups to support specific initiatives and legislation.